Results 1 to 10 of about 9,942,051 (298)
Some of the next articles are maybe not open access.
A drug safety evaluation of valsartan
Expert Opinion on Drug Safety, 2010Angiotensin receptor blockers (ARBs) as a class are generally considered safe and better tolerated than other antihypertensive drugs. The purpose of this report is to review the main data on the safety and tolerability of the second generation ARB valsartan after > 10 years since its initial approval.We searched Medline for clinical studies published ...
FOGARI, ROBERTO, Zoppi A.
openaire +2 more sources
Evaluation of safety-critical software
Communications of the ACM, 1990Methods and approaches for testing the reliability and trustworthiness of software remain among the most controversial issues facing this age of high technology. The authors present some of the crucial questions faced by software programmers and eventual users.
David Lorge Parnas +2 more
openaire +2 more sources
Drug safety evaluation of rotigotine
Expert Opinion on Drug Safety, 2012Rotigotine, a non-ergolinic dopamine-receptor agonist, is currently approved as monotherapy in early idiopathic Parkinson's disease (IPD), in moderate to severe idiopathic restless legs syndrome (RLS) and as adjunct therapy to levodopa in advanced IPD. Randomized, double-blind, placebo-controlled, as well as open-label studies were conducted in IPD and
Fabienne Stephanie, Sprenger +2 more
openaire +2 more sources
SAFETY EVALUATION OF ETHAMBUTOL
Annals of the New York Academy of Sciences, 1966H F, Diermeier, J A, Kaiser, N, Yuda
openaire +2 more sources
Using Human Genetics to Improve Safety Assessment of Therapeutics
Nature Reviews Drug Discovery, 2023Peter Newham +2 more
exaly
Solid-State Lithium Batteries: Safety and Prospects
EScience, 2022Liquan Chen, Yanbing He, Shichao Wu
exaly
THE SAFETY EVALUATION OF DRUGS
Annals of the New York Academy of Sciences, 1964openaire +2 more sources
An Overview of Real-World Data Sources for Oncology and Considerations for Research
Ca-A Cancer Journal for Clinicians, 2022Jennifer L. Lund +2 more
exaly

